Index - P/E - EPS (ttm) - Insider Own 68.45% Shs Outstand 151.95M Perf Week 3.44%
Market Cap 1.88B Forward P/E - EPS next Y - Insider Trans 7.50% Shs Float 48.18M Perf Month 14.27%
Income - PEG - EPS next Q -0.59 Inst Own 11.21% Short Float / Ratio 5.23% / 6.71 Perf Quarter -
Sales - P/S - EPS this Y - Inst Trans - Short Interest 2.52M Perf Half Y -
Book/sh 3.36 P/B 3.67 EPS next Y - ROA - Target Price 22.67 Perf Year -
Cash/sh 3.34 P/C 3.69 EPS next 5Y - ROE - 52W Range 9.35 - 17.74 Perf YTD -24.12%
Dividend - P/FCF - EPS past 5Y - ROI - 52W High -30.49% Beta -
Dividend % - Quick Ratio 18.05 Sales past 5Y 0.00% Gross Margin - 52W Low 31.87% ATR 0.82
Employees - Current Ratio 18.05 Sales Q/Q - Oper. Margin - RSI (14) 55.48 Volatility 4.82% 6.36%
Optionable Yes Debt/Eq 0.01 EPS Q/Q -244.89% Profit Margin - Rel Volume 0.62 Prev Close 12.25
Shortable Yes LT Debt/Eq 0.01 Earnings Nov 01 BMO Payout - Avg Volume 375.50K Price 12.33
Recom 1.00 SMA20 5.30% SMA50 8.11% SMA200 6.80% Volume 232,481 Change 0.65%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-10-23 Initiated William Blair
Outperform
$26
Oct-10-23 Initiated Stifel
Buy
$26
Oct-10-23 Initiated RBC Capital Mkts
Outperform
$24
Oct-10-23 Initiated JP Morgan
Overweight
$21
Oct-10-23 Initiated Guggenheim
Buy
$22
Oct-10-23 Initiated BofA Securities
Buy
$18
Nov-27-23 07:00AM
Nov-01-23 07:00AM
Oct-30-23 07:00AM
Oct-10-23 07:00AM
Sep-28-23 07:54PM
06:50PM
Loading…
Sep-27-23 06:50PM
Sep-18-23 12:35PM
Sep-14-23 08:49PM
Neumora Therapeutics, Inc. is a clinical-stage biotechnology company. It offers a precision medicine approach for brain diseases through the integration of data science and neuroscience. The firm focuses on advancing medicines for therapeutically relevant targets implicated in CNS diseases, targeting novel mechanisms of action with best-in-class pharmacology. The company was founded by Paul L. Berns, Carol Suh and Mike Poole in November 2019 and is headquartered in Watertown, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
ARCH Venture Partners XII, LLC 10% Owner Nov 14 Buy 11.98 3,357 40,217 4,131,207 Nov 15 06:54 PM Burow Kristina Director Nov 14 Buy 11.98 3,357 40,217 4,131,207 Nov 15 06:55 PM Burow Kristina Director Nov 13 Buy 11.75 31,653 371,923 4,127,850 Nov 15 06:55 PM ARCH Venture Partners XII, LLC 10% Owner Nov 13 Buy 11.75 31,653 371,923 4,127,850 Nov 15 06:54 PM Burow Kristina Director Nov 10 Buy 11.49 17,275 198,481 4,096,197 Nov 13 07:01 PM ARCH Venture Partners XII, LLC 10% Owner Nov 10 Buy 11.49 17,275 198,481 4,096,197 Nov 13 07:00 PM ARCH Venture Partners XII, LLC 10% Owner Nov 09 Buy 10.53 31,079 327,262 4,078,922 Nov 13 07:00 PM Burow Kristina Director Nov 09 Buy 10.53 31,079 327,262 4,078,922 Nov 13 07:01 PM Burow Kristina Director Nov 08 Buy 11.03 92,251 1,017,821 4,047,843 Nov 13 07:01 PM ARCH Venture Partners XII, LLC 10% Owner Nov 08 Buy 11.03 92,251 1,017,821 4,047,843 Nov 13 07:00 PM ARCH Venture Partners XII, LLC 10% Owner Nov 07 Buy 11.50 30,192 347,208 3,955,592 Nov 07 06:59 PM Burow Kristina Director Nov 07 Buy 11.50 30,192 347,208 3,955,592 Nov 07 07:00 PM Burow Kristina Director Nov 06 Buy 11.55 43,082 497,597 3,925,400 Nov 07 07:00 PM ARCH Venture Partners XII, LLC 10% Owner Nov 06 Buy 11.55 43,082 497,597 3,925,400 Nov 07 06:59 PM ARCH Venture Partners XII, LLC 10% Owner Nov 03 Buy 11.38 22,420 255,140 3,882,318 Nov 07 06:59 PM Burow Kristina Director Nov 03 Buy 11.38 22,420 255,140 3,882,318 Nov 07 07:00 PM ARCH Venture Partners XII, LLC 10% Owner Sep 29 Buy 13.98 34,560 483,149 3,859,898 Sep 29 06:53 PM Burow Kristina Director Sep 29 Buy 13.98 34,560 483,149 3,859,898 Sep 29 06:55 PM Burow Kristina Director Sep 28 Buy 13.44 41,951 563,699 3,825,338 Sep 29 06:55 PM ARCH Venture Partners XII, LLC 10% Owner Sep 28 Buy 13.44 41,951 563,699 3,825,338 Sep 29 06:53 PM Burow Kristina Director Sep 27 Buy 12.31 24,504 301,644 3,783,387 Sep 27 08:19 PM ARCH Venture Partners XII, LLC 10% Owner Sep 27 Buy 12.31 24,504 301,644 3,783,387 Sep 27 08:18 PM ARCH Venture Partners XII, LLC 10% Owner Sep 26 Buy 11.73 34,000 398,820 3,758,883 Sep 27 08:18 PM Burow Kristina Director Sep 26 Buy 11.73 34,000 398,820 3,758,883 Sep 27 08:19 PM Burow Kristina Director Sep 25 Buy 11.22 60,740 681,464 3,724,883 Sep 25 09:37 PM ARCH Venture Partners XII, LLC 10% Owner Sep 25 Buy 11.22 60,740 681,464 3,724,883 Sep 25 09:38 PM ARCH Venture Partners XII, LLC 10% Owner Sep 22 Buy 11.14 40,000 445,600 3,664,143 Sep 25 09:38 PM Burow Kristina Director Sep 22 Buy 11.14 40,000 445,600 3,664,143 Sep 25 09:37 PM AMGEN INC 10% Owner Sep 19 Buy 17.00 1,764,705 29,999,985 35,368,653 Sep 19 07:52 PM Burow Kristina Director Sep 19 Buy 17.00 1,500,000 25,500,000 3,624,143 Sep 20 06:23 AM ARCH Venture Partners X, LLC 10% Owner Sep 19 Buy 17.00 1,500,000 25,500,000 3,624,143 Sep 20 06:16 AM ARCH Venture Partners X, LLC 10% Owner Sep 19 Buy 17.00 1,500,000 25,500,000 3,624,143 Sep 20 06:15 AM Gosebruch Henry O President & CEO Sep 19 Buy 12.62 15,000 189,370 15,000 Sep 19 09:47 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
